Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression

Antibody‐mediated rejection (AMR) is one of the most dominant mechanisms responsible for the loss of kidney grafts. Previous researches have shown that donor‐specific antibodies (DSAs) are the major mediators of AMR. In order to prolong the survival time of grafts, it is vital to reduce the incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hong, Xu, Bin, Zhang, Lijie, Wang, Yi, Chen, Ming, Chen, Shuqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642675/
https://www.ncbi.nlm.nih.gov/pubmed/34734681
http://dx.doi.org/10.1111/jcmm.16998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642675/
https://www.ncbi.nlm.nih.gov/pubmed/34734681
http://dx.doi.org/10.1111/jcmm.16998

Ejemplares similares